Conditions

Research shows that psychedelics can be effective at treating a variety of mental health conditions and physical illnesses.

To learn best practices developed by harm reduction experts for the novice and intrepid psychonaut alike, start here.

Psychedelic use can be profound sometimes, helpful other times, risky occasionally, and in rare cases dangerous. Know your psychedelics.

Anxiety

Psychedelic therapy shows promise as a treatment for anxiety, including social anxiety and end-of-life anxiety

Depression

Research suggests that some psychedelic compounds may be useful in treating depression in conjunction with therapy

PTSD

MDMA and other substances have shown efficacy in research and anecdotally in treating PTSD

Substance Abuse Disorders

Studies suggest that psychedelic therapy could be an effective treatment for alcoholism and opioid dependency

Top Questions

Got Questions?

Search Psychedelic U to learn and discover.

The Latest in Conditions

Ketamine for Pain

July 6th, 2023

UPDATED: August 2nd, 2023

Ketamine research also suggests it has pain relieving qualities . A 2004 study analyzed…

Ketamine for Conditions

July 6th, 2023

UPDATED: August 2nd, 2023

Ketamine is being used to treat an array of mental health conditions and substance…

MDMA for PTSD

June 19th, 2023

UPDATED: July 21st, 2023

MDMA has the potential to be a treatment for the symptoms of PTSD for…

Ketamine for Anxiety

July 6th, 2023

UPDATED: July 21st, 2023

Research suggests ketamine can help with symptoms of generalized anxiety disorder and social anxiety.…

Ketamine for Depression

July 6th, 2023

UPDATED: July 21st, 2023

One of the most promising uses of ketamine in the mental health field is…

LSD for Alcohol Use Disorder

June 19th, 2023

UPDATED: July 21st, 2023

A landmark study on the use of LSD to treat alcohol use disorder occurred…

Stay Informed

Don’t miss the latest in the fast-moving psychedelics ecosystem. Get the Lucid News newsletter for headlines and updates to Psychedelic U.


Latest from Lucid News

Authors of Largest Microdosing Study Suggest Benefits Limited To Dosing Day

Recent research surveying 1,435 microdosers suggests that microdosing’s duration of effect might be more like that of drinking a coffee, with benefits that come and go by day’s end.

New RAND Report Shows Therapeutic Use Driving U.S. Views Towards Psychedelics

A new report from the RAND Corporation shows that nearly one-quarter of U.S. adults now support the legal use of psilocybin with public support driven by approval for therapeutic not personal access or recreational use.

New Theories and Findings From The Frontier of Ibogaine Research 

After publishing a new study investigating synthetic analogs for iboga molecules, scientist and co-founder of Gilgamesh Pharmaceuticals, Dalibor Sames, decided to take the compound he has described as an intelligent molecular machine.